Abbott India EV / EBITDA
Mi az Abbott India EV / EBITDA?
A EV / EBITDA az Abbott India Limited - 43.60
Mi a EV / EBITDA meghatározása?
Az EV / EBITDA a vállalati érték a kamat, az adózás, az értékcsökkenés és az amortizáció előtti eredményekkel elosztva. Ez azt jelenti, hogy mennyire drága egy állomány, és gyakrabban érvényesül a vállalatok közötti összehasonlításnál, mint az ár / nyereség arány. Megméri az árat (vállalati érték formájában), amelyet a befektető fizet a vállalat pénzforgalmának javára (EBITDA formájában).
Price to earnings ratios are impacted by a company's choice of capital structure - companies which raise money via debt will have lower P/Es (and therefore look cheaper) than companies that raise an equivalent amount of money by issuing shares, even though the two companies might have equivalent enterprise values. A sample case is when a company with debt were to raise money by issuing shares of stock, and then used the money to pay off the debt, this company's P/E ratio would shoot up because of the increased number of shares - although nothing about the fundamental value of the business has changed. EV / EBITDA is unaffected by capital structure as enterprise value includes the value of debt, and EBITDA is available to all investors (debt and equity) as it excludes interest payments on that debt. It is ideal for analysts and potential investors looking to compare companies within the same industry.
EV / EBITDA a Health Care szektor a BSE-on cégekben a Abbott India -hoz képest
Mit csinál Abbott India?
Abbott India Limited operates as a pharmaceutical company in India. It offers pharmaceutical products for various therapeutic areas, such as women's health, gastroenterology, metabolics, central nervous system, pain management, nutritional supplements, vitamins, insomnia, vaccines, consumer health, etc. The company was formerly known as Knoll Pharmaceuticals Limited and changed its name to Abbott India Limited in July 2002. Abbott India Limited was founded in 1944 and is headquartered in Mumbai, India. Abbott India Limited operates as a subsidiary of Abbott Laboratories
ev / ebitda -hoz hasonló cégek Abbott India
- PaySign nak EV / EBITDA 43.41 van
- B & D Strategic nak EV / EBITDA 43.44 van
- China Apex nak EV / EBITDA 43.47 van
- Xref nak EV / EBITDA 43.47 van
- AK Medical nak EV / EBITDA 43.51 van
- Escorts nak EV / EBITDA 43.55 van
- Abbott India nak EV / EBITDA 43.60 van
- ADC India Communications nak EV / EBITDA 43.63 van
- Elecon Engineering nak EV / EBITDA 43.68 van
- V.S. International nak EV / EBITDA 43.90 van
- Harvest Minerals nak EV / EBITDA 43.94 van
- Pritish Nandy Communications Ltd nak EV / EBITDA 43.96 van
- Satu nak EV / EBITDA 44.04 van